Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.89 USD | -1.45% | +23.00% | -9.92% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.92% | 235M | |
+31.06% | 456B | |
+33.63% | 280B | |
+3.90% | 134B | |
+30.50% | 94.31B | |
+62.27% | 60.48B | |
+14.09% | 46.13B | |
+25.91% | 37.31B | |
-0.62% | 35.48B | |
+12.07% | 28.36B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- B. Riley Securities Lowers OptimizeRx's Price Target to $37 from $56 After Lower-than-Expected Q2 Results, Keeps Buy Rating